Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 241 - 260 of 465
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2013, 11:49 am by Bexis
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
11 Jan 2013, 6:27 pm by Prashant Reddy
The patents for the remaining two drugs – Ixabepilone and Dastinib are owned by Bristol Myers Squibbs (BMS). [read post]
15 Oct 2012, 1:24 am by Kevin LaCroix
It is not even the largest securities suit settlement, having been exceeded, among others, by Bristol Myers Squibb’s $300 million securities lawsuit settlement (about which refer here). [read post]
4 Sep 2012, 1:45 pm by Rodney Mesriani
Experts further expected that the new drug will generate more sales to its manufacturer since its competing experimental drug from Bristol-Myers Squibb. [read post]
4 Sep 2012, 7:31 am by arester
Skadden, Arps, Slate, Meagher & Flom LLP was hired by Amylin to perform delicate corporate surgery, first extracting the diabetes-drug developer—along with, Bydureon, its most valuable drug—from a soured pact with Eli Lilly & Co. and then helping to sell the company to Bristol-Myers Squibb Co. in a $5.1 billion deal that closed in August... [read post]
22 Aug 2012, 7:51 am by arester
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
22 Aug 2012, 6:09 am
Drug companies including Pfizer, Merck & Co. and Bristol Myers-Squibb Co. are squeezed by rising research costs, the weak global economy and pressure from Europe, China and elsewhere to reduce drug prices. [read post]
17 Aug 2012, 5:35 am by admin
As a high-level executive in the treasury department at Bristol-Myers Squibb, Robert D. [read post]
7 Aug 2012, 10:06 am by The Docket Navigator
Bristol-Myers Squibb Company, 1-12-cv-00394 (DED August 3, 2012, Order) (MDL Panel). [read post]
7 Aug 2012, 8:10 am by Robert J. Tannous
On August 2, 2012, the Securities and Exchanges Commission ("SEC") charged an executive in the treasury department at Bristol-Myers Squibb with insider trading. [read post]
3 Aug 2012, 4:29 am by Broc Romanek
" Insider Trading for Dummies: Don't Google "How to Avoid Getting Caught" Yesterday, the SEC issued this press release charging a guy in Bristol-Myers Squibb's Treasury department with insider trading on confidential information about companies being targeted for potential acquisitions.. [read post]
2 Aug 2012, 1:20 pm by Securites Lawprof
Ramnarine, an executive at Bristol-Myers Squibb, with insider trading on confidential information about companies being targeted for potential acquisitions. [read post]
1 Jul 2012, 2:54 am
T 0134/10 A patent in the name of Colgate-Palmolive Company relating to pearlised cleansing compositions was opposed by The Procter & Gamble Company and Sasol Germany GmbH. [read post]
30 Jun 2012, 9:12 am by Cal Warriner
Late Friday, June 29, Bristol-Myers Squibb announced it was buying the pharmaceutical company and paying off some debt to Eli Lilly & Co for a reported deal worth $7 billion. [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]
30 May 2012, 1:37 pm by Peter Rost
Example:MEDIATIME: "CURBING DRUG-COMPANY ABUSES: ARE FINES ENOUGH? [read post]
Following the passage of the bylaw deadline, Icahn sought to nominate candidates for election to Amylin's board of directors in the wake of his learning of Amylin's recent rejection of an unsolicited takeover proposal by Bristol-Myers Squibb Co. [read post]
24 May 2012, 4:23 am by Max Kennerly, Esq.
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]